Biopharm...What's going on?
- Thread starter anonymous
- Start date
-
- Tags
- None
<
there's good news and bad news. good news, the danes invented a time machine so they can go back and fix the decision not to acquire ACE910. bad news, the ET decided that doing so isn't synergistic with the biopharm vision of returning to growth by 2020. nothing to worry about though, they'll be sure to launch N8-GP (naturally, without the prophylaxis indication due to PEG) several years after every competitors' extended half-life FVIIIs. and why take Hemlibra/ACE910 once a week or once a month when you can use concizumab every day with a best-in-class device? 
The almighty queen of Sanofi, err Pia, is swinging us back to growth!
Don't hold your breath waiting for concizumab, it's going to be closed down due to safety issues. To be announced in the half year earnings release, together with many other interesting things...there's good news and bad news. good news, the danes invented a time machine so they can go back and fix the decision not to acquire ACE910. bad news, the ET decided that doing so isn't synergistic with the biopharm vision of returning to growth by 2020. nothing to worry about though, they'll be sure to launch N8-GP (naturally, without the prophylaxis indication due to PEG) several years after every competitors' extended half-life FVIIIs. and why take Hemlibra/ACE910 once a week or once a month when you can use concizumab every day with a best-in-class device?